Cargando…

Randomized Controlled Trial Comparing the Efficacy of Sustained-Release Formula of Mosapride-Plus-Esomeprazole Combination Therapy to Esomeprazole Monotherapy in Patients with Gastroesophageal Reflux Disease

We aimed to evaluate whether adding a sustained-release (SR) formula of mosapride to proton-pump inhibitors (PPIs) would be more effective in controlling symptoms than PPI alone in patients with gastroesophageal reflux disease (GERD). Sixty patients with heartburn and/or regurgitation were randomly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeon, Hye Kyung, Kim, Gwang Ha, Lee, Moon Won, Joo, Dong Chan, Lee, Bong Eun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999938/ https://www.ncbi.nlm.nih.gov/pubmed/35407572 http://dx.doi.org/10.3390/jcm11071965

Ejemplares similares

A Double-blind, Randomized, Multicenter Clinical Trial Investigating the Efficacy and Safety of Esomeprazole Single Therapy Versus Mosapride and Esomeprazole Combined Therapy in Patients with Esophageal Reflux Disease
por: Lee, Ju Yup, et al.
Publicado: (2017)

A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD)
por: Kalaitzakis, Evangelos, et al.
Publicado: (2007)

Management of gastroesophageal reflux disease and erosive esophagitis in pediatric patients: focus on delayed-release esomeprazole
por: Guimarães, Elizabet V, et al.
Publicado: (2010)

Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
por: Cardile, Sabrina, et al.
Publicado: (2012)

Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients – focus on esomeprazole
por: Tang, Raymond SY, et al.
Publicado: (2013)

Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease
por: Orlando, Roy C, et al.
Publicado: (2010)

Short-Term Symptomatic Relief in Gastroesophageal Reflux Disease: A Comparative Study of Esomeprazole and Vonoprazan
por: Sakurai, Kouichi, et al.
Publicado: (2018)

Efficacy and Safety of Esomeprazole for the Treatment of Reflux Symptoms in Patients with Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis
por: HOU, Mingxing, et al.
Publicado: (2020)

Rabeprazole and esomeprazole in mild-to-moderate erosive gastroesophageal reflux disease: A comparative study of efficacy and safety
por: Maiti, Rituparna, et al.
Publicado: (2011)

Lansoprazole plus levosulpiride versus esomeprazole in participants with gastroesophageal reflux disease and erosive esophagitis: a double blinded randomized control trial
por: Umer, Muhammad Rizwan, et al.
Publicado: (2023)

Induced Sputum Substance P in Children with Difficult-to-Treat Bronchial Asthma and Gastroesophageal Reflux: Effect of Esomeprazole Therapy
por: Bediwy, Adel Salah, et al.
Publicado: (2011)

Effects of Tegoprazan Versus Esomeprazole on Nighttime Heartburn and Sleep Quality in Gastroesophageal Reflux Disease: A Multicenter Double-blind Randomized Controlled Trial
por: Kim, Joon Sung, et al.
Publicado: (2023)

On-demand versus half-dose continuous therapy with esomeprazole for maintenance treatment of gastroesophageal reflux disease: A randomized comparative study
por: Cho, Joon Hyun, et al.
Publicado: (2018)

The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazole
por: Degl' Innocenti, Alessio, et al.
Publicado: (2005)

Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease
por: Bayerdörffer, Ekkehard, et al.
Publicado: (2016)

Comparative Pharmacokinetics/Pharmacodynamics of Fixed-Dose Combination of Esomeprazole and Calcium Carbonate (AD-206) to the Conventional Esomeprazole
por: Bae, Sungyeun, et al.
Publicado: (2021)

The Benefits of Combination Therapy with Esomeprazole and Rebamipide in Symptom Improvement in Reflux Esophagitis: An International Multicenter Study
por: Hong, Su Jin, et al.
Publicado: (2016)

Effect of esomeprazole on the pharmacokinetics of carbamazepine
por: Medhi, Bikash, et al.
Publicado: (2011)

Clinical Characteristics of Patients with Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitors and the Effects of Switching to 20 mg Esomeprazole on Reflux Symptoms and Quality of Life
por: Takeshima, Fuminao, et al.
Publicado: (2015)

Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study
por: Gunasekaran, Thirumazhisai, et al.
Publicado: (2009)

First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease
por: Liang, Chih-Ming, et al.
Publicado: (2017)

Influence of the Impregnation Technique on the Release of Esomeprazole from Various Bioaerogels
por: Pantić, Milica, et al.
Publicado: (2021)

Pharmacokinetics of Esomeprazole in Critically Ill Patients
por: Xu, Yanyan, et al.
Publicado: (2022)

A Randomized, Double-Blind, Active-Control, Noninferiority, Multicenter, Phase 4 Study to Evaluate the Efficacy and Safety of Esomeprazole/Sodium Bicarbonate 20/800 mg in Patients with Nonerosive Gastroesophageal Reflux Disease
por: Park, Su Hyun, et al.
Publicado: (2023)

Preparation and Characterization of Controlled-Release Floating Bilayer Tablets of Esomeprazole and Clarithromycin
por: Israr, Muhammad, et al.
Publicado: (2022)

Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial
por: Sun, Qing-Hua, et al.
Publicado: (2019)

Additional Mosapride to Proton Pump Inhibitor for Gastroesophageal Reflux Disease: A Meta-Analysis
por: Nishizawa, Toshihiro, et al.
Publicado: (2020)

Pharmacokinetics and pharmacodynamics of intravenous esomeprazole at 2 different dosages in dogs
por: Seo, Do‐Hyun, et al.
Publicado: (2018)

Crystallization of Esomeprazole Magnesium Water/Butanol Solvate
por: Skieneh, Jenna, et al.
Publicado: (2016)

Mandibular Osteonecrosis Associated with Antacid Therapy (Esomeprazole)
por: Marconcini, Simone, et al.
Publicado: (2019)

Esomeprazole and apixaban pharmacokinetic interactions in healthy rats
por: Jaber, Ali, et al.
Publicado: (2022)

Complexity in Estimation of Esomeprazole and its Related Impurities’ Stability in Various Stress Conditions in Low-Dose Aspirin and Esomeprazole Magnesium Capsules
por: Reddy, Palavai Sripal, et al.
Publicado: (2013)

Simultaneous Estimation of Esomeprazole and Domperidone by UV Spectrophotometric Method
por: Prabu, S. Lakshmana, et al.
Publicado: (2008)

Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events
por: Sylvester, Katelyn W, et al.
Publicado: (2013)

Effects of Plasma Albumin on the Pharmacokinetics of Esomeprazole in ICU Patients
por: Tian, Hsin, et al.
Publicado: (2018)

The pharmacokinetics and pharmacodynamics of esomeprazole in sheep after intravenous dosing
por: Smith, Joe S., et al.
Publicado: (2023)

Efficacy of the four weeks treatment of omeprazole plus mosapride combination therapy compared with that of omeprazole monotherapy in patients with proton pump inhibitor-refractory gastroesophageal reflux disease: a randomized controlled trial
por: Sirinawasatien, Apichet, et al.
Publicado: (2019)

Retraction note to: Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial
por: Sun, Qing-Hua, et al.
Publicado: (2023)

Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis
por: Lee, Kang Nyeong, et al.
Publicado: (2022)

Therapeutic Efficacy of Esomeprazole in Cotton Smoke-Induced Lung Injury Model
por: Nelson, Christina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_07ag4kicavufr9dkeuaevm5fl3